Prediction Case File
YouTubeEvaluation Complete

Oracle Stock Prediction and Forecast [ORCL]

1 extracted signal · 1 resolved · 0 still active

StockInvest.us profile imageStockInvest.us11 Mar 2026, 03:36 UTC
Video preview for Oracle Stock Prediction and Forecast [ORCL]
Signals
1
Eligible signals in this source
Open
0
Still being tracked
Resolved
1
Evaluable outcomes
Successful
1
Canonical correct result
Failed
0
Canonical failed result
Resolved success
100%
Open and excluded signals omitted
Source overview

AI-generated source summary

Oracle exhibits several negative technical signals and is in a wide falling trend. Despite recent positive news regarding AI and cloud contracts, the stock is expected to perform weakly in the short to medium term. Analysts have downgraded Oracle from a 'Hold' to a 'Sell' candidate, citing minor technical weaknesses and anticipating further price declines. Key resistance levels to watch are $151.33 and $157.40. A break above these levels could signal a potential reversal, but the current outlook remains bearish.

AI-generated summary based on the source content.

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  3. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

  4. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  5. Market predictions extracted

    1 eligible signal linked to this case.

  6. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

Extracted intelligence

Signals in this source

Continue the evidence trail
Analyst history

StockInvest.us

Tracked signals
1521
Historical success
43.3%
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.